530057 logo

Vivanza Biosciences Limited Stock Price

BSE:530057 Community·₹82.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

530057 Share Price Performance

₹2.05
-1.78 (-46.48%)
₹2.05
-1.78 (-46.48%)
Price ₹2.05

530057 Community Narratives

There are no narratives available yet.

Recent 530057 News & Updates

Vivanza Biosciences Limited Key Details

₹140.0m

Revenue

₹135.5m

Cost of Revenue

₹4.4m

Gross Profit

₹13.0m

Other Expenses

-₹8.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.21
Gross Margin
3.17%
Net Profit Margin
-6.09%
Debt/Equity Ratio
218.3%

Vivanza Biosciences Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Slight risk and slightly overvalued.

4 Risks
0 Rewards

About 530057

Founded
1982
Employees
8
CEO
Jayendra Mehta
WebsiteView website
vivanzabiosciences.com

Vivanza Biosciences Limited engages in the research, development, manufacture, and distribution of pharmaceutical products in India. It offers latex surgical and examination, and latex free examination gloves, as well as other surgical products. The company was incorporated in 1982 and is based in Ahmedabad, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. Longer term the market is actually down 4.7% over the past year. Earnings are forecast to grow by 16% annually. Market details ›